Published in Curr Pharm Des on January 01, 2012
Retracted Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia. Diagn Pathol (2014) 1.39
Diagnosis and management of giant hepatic hemangioma: the usefulness of contrast-enhanced ultrasonography. Int J Hepatol (2013) 0.87
Quantitative evaluation of contrast-enhanced ultrasonography in the diagnosis of chronic ischemic renal disease in a dog model. PLoS One (2013) 0.87
Fortuitously discovered liver lesions. World J Gastroenterol (2013) 0.82
Clinical impact of ultrasound-related techniques on the diagnosis of focal liver lesions. Liver Cancer (2012) 0.79
Contrast-Enhanced Ultrasound for the Characterization of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Liver Cancer (2015) 0.77
Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound--A Prospective Study in Non-Cirrhotic Patients. PLoS One (2015) 0.75
Optical architecture design for detection of absorbers embedded in visceral fat. Biomed Opt Express (2014) 0.75
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. Hepatology (2011) 4.60
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology (2005) 2.50
The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol (2009) 2.47
Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol (2012) 2.39
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. J Hepatol (2013) 2.23
When to perform hepatic resection for intermediate-stage hepatocellular carcinoma. Hepatology (2015) 2.15
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl (2005) 2.04
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann Surg Oncol (2008) 1.98
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis (2013) 1.85
Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. Liver Int (2013) 1.57
Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology (2011) 1.50
Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl (2005) 1.30
Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy. Liver Transpl (2011) 1.22
Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. Eur J Radiol (2012) 1.18
Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol (2008) 1.11
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study. Int J Cancer (2014) 1.11
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. J Hepatol (2010) 1.06
Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. J Hepatol (2012) 1.05
Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. J Hepatol (2013) 1.04
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. Dig Liver Dis (2013) 1.02
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol (2013) 1.00
Expression of reelin in hepatic stellate cells and during hepatic tissue repair: a novel marker for the differentiation of HSC from other liver myofibroblasts. J Hepatol (2002) 0.99
Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol (2004) 0.97
A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma. Scand J Gastroenterol (2009) 0.94
Characterization of liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol (2007) 0.94
Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol (2013) 0.89
Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation. Liver Transpl (2009) 0.89
Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension? J Vasc Interv Radiol (2013) 0.89
Role of contrast-enhanced ultrasonography in primary hepatic lymphoma. J Ultrasound Med (2010) 0.88
Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol (2013) 0.88
Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. Eur J Radiol (2011) 0.86
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Clin Cancer Res (2012) 0.86
Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. Dig Liver Dis (2010) 0.85
The influence of aminotransferase levels on liver stiffness assessed by Acoustic Radiation Force Impulse Elastography: a retrospective multicentre study. Dig Liver Dis (2013) 0.85
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma. Liver Cancer (2012) 0.83
Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. J Hepatol (2005) 0.82
Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. Dig Liver Dis (2012) 0.82
Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C. Liver Transpl (2006) 0.81
Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up. Artif Organs (2013) 0.81
Metronomic capecitabine in patients with hepatocellular carcinoma unresponsive to or ineligible for sorafenib treatment: report of two cases. Hepat Mon (2013) 0.81
Onset of bronchiolitis obliterans organizing pneumonia in a liver transplant recipient under peg-interferon and ribavirin treatment. Intern Emerg Med (2008) 0.80
The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series. Dig Dis (2014) 0.80
Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma. Mol Imaging Biol (2015) 0.80
In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair. J Hepatol (2003) 0.79
Relationship between hepatic haemodynamics assessed by Doppler ultrasound and liver stiffness. Dig Liver Dis (2011) 0.78
Outcomes from a program of home care attendance in very frail elderly subjects. Arch Gerontol Geriatr (2006) 0.78
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? Clin Transplant (2009) 0.77
Recent advances in the imaging of hepatocellular carcinoma. From ultrasound to positron emission tomography scan. Saudi Med J (2007) 0.76
Effect of Levovist on splanchnic hemodynamics in cirrhotic patients. Ultrasound Med Biol (2003) 0.76
Yttrium 90 radioembolization: the horizon is changing for patients with intermediate and advanced hepatocellular carcinoma. Hepatology (2013) 0.75
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selection. Hepatology (2009) 0.75
Portal pressure and Doppler. Ultrasound Med Biol (2003) 0.75
Selecting patients with hepatocellular carcinoma for transplantation. Liver Transpl (2007) 0.75
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice? Ann Surg (2009) 0.75
Reply to: "non-invasive diagnosis of small nodules in cirrhosis". J Hepatol (2013) 0.75
Letter to the editor. Ultraschall Med (2012) 0.75
Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis C after transplantation. Liver Transpl (2010) 0.75
Echo-enhanced ultrasonography: is it the future gold standard of imaging in acute pancreatitis? JOP (2005) 0.75
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. Dig Liver Dis (2011) 0.75
Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection. Eur J Gastroenterol Hepatol (2013) 0.75
Hepatic artery thrombosis and graft ischemia in the presence of preserved arterial inflow: not a contradiction but a real possibility. Liver Transpl (2004) 0.75
Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis. Clin Gastroenterol Hepatol (2006) 0.75